Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports .
💡 : Use the SEC EDGAR Database to review the latest prospectus and full risk disclosures for these ETFs before investing. If you'd like to narrow this down, tell me: best biotech etf to buy now
7 Best Biotech ETFs to Buy Now | Investing - U.S. News Money Strategy: Actively managed by Cathie Wood's team, targeting